Evidence map›Paper›PMID 28058114›Full record

ArticleIranian Red Crescent medical journal2016

Protective Effects of Co-Enzyme Q10 on Thioacetamide-Induced Acute Liver Damage and Its Correlation With Behavioral, Biochemical, and Pathological Factors.

Soheil Ashkani-Esfahani, Fereshteh Bagheri, Yasaman Emami, Elmira Esmaeilzadeh, Negar Azarpira, Nazila Hassanabadi, Marzieh Keshtkar, Mojtaba Farjam, Omid Koohi-Hosseinabadi, Ali Noorafshan

Open access · greenAbstract read
In one paragraph

Article in Iranian Red Crescent medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Soheil Ashkani-EsfahaniStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Fereshteh BagheriStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Yasaman EmamiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Elmira EsmaeilzadehStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Negar AzarpiraOrgan Transplant Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Nazila HassanabadiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Marzieh KeshtkarInternational Branch, Shiraz University of Medical Sciences, Kish, IR Iran.
Mojtaba FarjamDepartment Of Pharmacology, Fasa University of Medical Sciences, Shiraz, IR Iran.
Omid Koohi-HosseinabadiCenter of Comparative and Experimental Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Ali NoorafshanHistomorphometry and Stereology Research Centre, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Shiraz University of Medical Sciences · IRFasa University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute liver damage may be followed by biochemical, behavioral, and pathological alterations, which can result in serious complications and even death.

objectivesIn this experimental study we determined whether coenzyme Q10 (CoQ10), a common supplementary medicine known to have protective, antioxidative, and anti-inflammatory effects in cells, has any protective effect against thioacetamide (TAA)-induced liver damage and its related neurobehavioral alterations in rats. MATERIALS AND

methodsIn this experimental study forty-eight Wistar rats were divided randomly into four groups (n = 12): C1 was the control group; C2 received a single-dose of TAA (350mg/kg; intraperitoneally) without any other treatment; E1 received TAA + 5 mg/kg CoQ10 (intraperitoneally); and E2 received TAA + 10 mg/kg CoQ10. After sacrificing the rats, liver enzymes and plasma-ammonia (NH4) were measured and histopathological analyses of the livers were carried out. Elevated-plus-maze, open-field, and forced-swimming tests were also performed to investigate behavioral correlations.

resultsThe serum levels of alanine-aminotransferase (ALT), aspartate-aminotransferase (AST), and NH4 show significant increases (P < 0.05). The groups treated with CoQ10 were shown to have significantly lower clinical grade of encephalopathy (P = 0.001), higher locomotor activity (P = 0.000), and lower levels of depression (P = 0.000). Furthermore, it was also shown that CoQ10 treatment may lead to significant decreases in scores of centrilobular necrosis, apoptosis, inflammatory cell infiltration, vacuolization, and liver necrosis (P < 0.05).

conclusionsOverall, CoQ10 was determined to have positive effects on liver injury and its related behavioral and biochemical changes.

Indexed as

Acute liver FailureBehavioral SymptomsCoenzyme Q10HyperammonemiaThioacetamide

Identifiers

PMID28058114
PMCPMC5192999
OpenAlexW2442750088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.